ÂåÀø¾¹§÷¥Íª«¬Û®e©Ê¸ÕÅçISO10993¹ê°È
¥»½Òµ{³z¹L¥Íª«¬Û®e©Ê±M·~ª¾ÃÑ»P¹ê°È¸gÅç¤À¨É¡AÀ°§U¾Çû´x´¤ISO 10993...
ÂåÀø¾¹§÷¥Íª«¬Û®e©Ê¸ÕÅçISO10993¹ê°È
½T©w¶}¯Z
½Òµ{«¬ºA/ ½u¤W¦P¨B
¤W½Ò¦a§}/ Webex ½u¤W·|ij«Ç
®É¼Æ/ 12¤p®É
°_¨´¤é´Á/ 2023/02/20~2023/02/21
Ápµ¸¸ê°T/ ÁªéªY 02-23701111#312
³ø¦WºI¤î¤é/ 2023/02/13
-------------------------------
½Òµ{¤¶²Ð
½Ã¥ÍºÖ§Q³¡©ó2021¦~5¤ë1¤é¬I¦æ¡uÂåÀø¾¹§÷§Þ³N¤HûºÞ²z¿ìªk¡v¡A³W©w¿é¤JÂåÀø¾¹§÷§Þ³N¤HûÀ³¦³ªñ5¦~¤º±µ¨ü¦Ü¤Ö20¤p®É¥H¤W¤§±Ð¨|°V½m¡FµL½×¬OÂåÀø¾¹§÷»s³y·~©Î³c½æ·~ªº§Þ³N¤Hû¡A©ó·~ªÌ¨Ìªk¿ì²zµn°O¤§¤é°_¡A¨C¦~À³±µ¨ü8¤p®ÉÄ~Äò±Ð¨|°V½m¡A¤u¬ã°|²£·~¾Ç°|¬°½ÃºÖ³¡®Ö¥i¿ì²zÂå§÷¤Hû°V½m¤Î»{ÃÒ¤§¦X®æ³æ¦ì¡A½Òµ{§¹°V«á¥i¥Ó½Ð®É¼Æ»{ÃÒ¡A±©¹ê»Ú¥Ó½Ð¤´¥H½ÃºÖ³¡¬d®Öµ²ªG¬°·Ç¡A·qÁܾÇû¿ãÅD³ø¦W¡C
¥Íª«¦M®`µû¦ô¬O¥ÍÂå²£«~¦w¥þ»P¥\®Äµû¦ô«nªº½ÒÃD¤§¤@¡A¤Z¬O·|»P¤H±µÄ²¤§²£«~(¦pÂåÀø¾¹§÷¡Bì®Æ¡B¤ÆùÛ«~)¬Ò»Ýn¶i¦æ¥Íª«¬Û®e©Êµû¦ô¡C¥Íª«¬Û®e©Ê´ú¸Õªº¥Øªº´N¬On½T«O¤HÅé¦b±µÄ²¨ì§÷®Æ«á¡A§÷½è不·|ÄÀ©ñ¦³¬rª«½è¡A³y¦¨§½³¡©Î¥þ¨©Ê²ÓM¬r©Ê¡BPÀù©Ê¤Î¥Í´Þ¬r©Ê¡A¤HÅé¦b±µÄ²¨ì§÷®Æ«á¤£·|¤Þ°_µoª¢¤ÏÀ³¡B§K¬Ì¤ÏÀ³¡B¬r©Ê¤ÏÀ³¡B¦å®ê§Î¦¨¤ÏÀ³µ¥¦M®`¡C
°ê»Ú¤W¹ï©ó¥Íª«¬Û®e©Ê¤§µû¦ô¥Dn°Ñ¦Ò¨Ì¾Ú¬°ISO10993-1¡G2018¡A·sª©±N쥻ª©ÂåÀø¾¹§÷¥Íª«¬Û®e©Êªº´ú¸Õ¥Ñì¨Óªº±Ä¥Î¨Ì±µÄ²®É¶¡»P±µÄ²¦ì¸mªºµû¦ô¼Ò¦¡¡AÂàÅܬ°°ò©ó·ÀIºÞ²zµû¦ô¤è¦¡¶i¦æ¬ÛÃöµû¦ô»P³Ì²×¥Íª«´ú¸Õ¡C
¥»½Òµ{³z¹L¥Íª«¬Û®e©Ê±M·~ª¾ÃÑ»P¹ê°È¸gÅç¤À¨É¡AÀ°§U¾Çû´x´¤ISO 10993ªº°ò¥»¬[ºc¡A¥H¤Î«Ø¥ß²£«~¥Íª«¬Û®e©Ê·ÀI¤ÀªRµû¦ôªº³Ì¾A¤Á¤è®×¡A´£¤É²£«~«~½è¡A°§CÅçÃÒ¦¨¥»»P®É¶¡¡A¥H´£¤É²£«~¤W¥««á®Ä¯q¡C
¦]À³·s«aªÍª¢(COVID-19)¨¾¬Ì³W½d¡A½Òµ{´£¨Ñ¡i¼Æ¦ì¦P¨B¾Ç²ß¡j³ø¦W¤è®×¡AÅwªï¾Çû³ø¦W°Ñ¥[¡C
¤W½Ò®É¶¡¡G112¦~2¤ë20¤é(¤@)¡B2¤ë21¤é(¤G)¡A9:30am~16:30pm¡A¦@p12¤p®É¡C
¤W½Ò¦aÂI¡GWebex ½u¤W·|ij«Ç
½Òµ{Ápµ¸¤H¡G02-2370-1111#312¡AÁ¤p©j
¡°¥»½Òµ{Åwªï¥ø·~¥]¯Z~½Ð¨Ó¹q¬¢¸ß ©Ó¿ì¤H·¨¤p©j02-2370-1111#320
½Òµ{¥Ø¼Ð
1. «Øºc¾Çû¹ï²£«~¥Íª«¬Û®e©Ê¸ÕÅç(ISO 10993)¦³°ò¥»·§©À¤Î¹ê°ÈÀ³¥Î¯à¤O¡C
2. Åý¾ÇûÁA¸Ñ²£«~¥Íª«¬Û®e©Ê·ÀI¤ÀªRµû¦ô¤èªk¡A«Ø¥ß³Ì¾A¤Á¤è®×¡C
½Òµ{¹ï¶H
- ÂåÀø¾¹§÷·s¶i¤Hû¤Î¦b¾¤Hû°V½m¡C
- ¤j±M¥H¤W¦U¬ì¨t¾Ç¥Í¤ÎªÀ·|¤H¤h¡A¹ïÂåÀø¾¹§÷²£·~¤ÎÂå¾Ç»â°ì¦³¿³½ìªÌ¡C
- ±q¨Æ¹q¤l¡B§÷®Æ¡B³]³Æ¡B»sÃÄ¡B¥Í§Þ²£·~¤ÎÁ{§ÉÂå¾Ç¤§²§·~·Q§ë¤JÂåÀø¾¹§÷²£·~ªÌ¡C
½Òµ{¤jºõ
¤@¡B¥Íª«¬Û®e©Ê¸ÕÅ粤¶
¤G¡BISO 10993¥Íª«¬Û®e©Ê¼Ð·Ç³W½d
¤T¡BISO 10993·ÀIºÞ²z½d³òªºµû¦ôµ{§Ç¤Î´ú¸Õ
¥|¡BISO 10993-17¬r²zµû¦ô»P¨ä¥¦·»¥X¸ÕÅ礶²Ð»P®×¨Ò¤À¨É
¤¡BISO 10993-18¤Æ¾Çªí¼xµû¦ô¤¶²Ð»P¹ê¨Ò¤À¨É
¤»¡B¦p¦ó¿ï¾Ü¥Íª«µû¦ô¤èªk»P°õ¦æ«ÂI
¤C¡B±`¨£¥Íª«¬Û®e©Ê®×¨Ò°Q½×»P¹ê°È¸gÅç¤À¨É
Á¿®v²¤¶-¬xÁ¿®v
²{¾ :
ÅçÃÒ¤½¥q Lead Auditor/Assessor/Expert¡BMEDPOINT Lead auditor for pharma/MD industry supplier audit¡Beurofins IVD CE MARKING ¨È¬w½]®Ö^¤å¤fĶû¡B°]¹Îªk¤H¦Û±j°òª÷·|¥~¸uÅU°ÝÁ¿®v¡B°]¹Îªk¤H¦¨¤j°òª÷·|¥~¸uÅU°ÝÁ¿®v
¾Ç¾ú :
¤¤°êÂåÃĤj¾ÇÃľǨt¡B¾Ç¤h«á¤¤Âå¾Ç¨t/¤¤¿³¤j¾Ç¥Í©R¬ì¾Ç¨t¡B¤Æ¤u¨t¬ã¨s©Ò
¸g¾ú :
- GMP ¤¤¦èÃļt¡B¤Æ§©«~¡B¹«~¼t«~ºÞ¡B»s³y¡B¬ãµo
- ì®ÆÃľǦWÃĤƾǦX¦¨Ãļt«~ºÞ¡B¬ãµo
- Àô«O¸p»{¥iÀô¹Ò¥NÀËÅç·~¹êÅç«Ç¥D¥ô¡B·~°È¸g²z
- ¤u¬ã°|¶q´ú¤¤¤ßÂåÀø¾¹§÷Gamma¿ç®g·Àµß½T®Ä¬ã¨spµe¥D«ù¤H
- »OÆW°Êª«¬ì¾Ç¬ã¨s©Ò¥Íª«¤H¤u¥Ö½§GMP¤u¼t³W¹º³]p¬I¤u¡B¥Íª«¤H¤u¥Ö½§¶}µo¥~¸u±M®×±M®aÅU°Ý
- GMPÂåÀø¾¹§÷¼t«~«O¡B¬ãµo±M®×¸g²z
- °]¹Îªk¤H¥xÆW¹q¤lÀËÅ礤¤ß¥~¸uÂåÀø¾¹§÷ GMP ½]®Öû
- °]¹Îªk¤Hª÷Äݤu·~¬ã¨s¤¤¤ß ¥~¸uÂåÀø¾¹§÷ GMP ½]®Öû
- °]¹Îªk¤H¯¼Â´²£·~ºî¦X¬ã¨s©Ò¥~¸uÂåÀø¾¹§÷Á¿®v
- °]¹Îªk¤H¶ì½¦µo®i¤¤¤ß¥~¸uÂåÀø¾¹§÷ÅU°Ý Á¿®v
- SQA associate auditor for pharma/MD industry supplier auditor
»ù®æ(½u¤W¾A¥Î)
¡°¥»½Òµ{¾A¥Î¡i5¤H³ø¦W¬ã²ß1¤H§K¶O¡j¬¡°Ê¡A¤Z³ø¦W¥»½Òµ{¬Ò¥i¨É¦³¤¤H°Ñ°V¤@¤H§K¶O¤§«P¾P¤è®×¡AÅwªï¥ø·~²Õ¹Î°Ñ°V¡C
¤è®× |
¶O¥Î |
½Òµ{ì»ù(Ó¤H) |
7,800 |
¦³¾Àu´f»ù10¤Ñ«e³ø¦WÀu´f»ù |
7,200 |
2¤H´ª¹Î¦P¦æÀu´f»ù |
6,800 |
5¤H¦P¦æ1¤H§K¶OÀu´f»ù |
6,240 |
¤u¬ã¤HÀu´f»ù |
7,200 |
ª`·N¨Æ¶µ
- ¥»½Òµ{±Ä³ø¦W¨î¡Aº¡10¤H¥H¤W¶}¯Z¡A¥¼º¡10¤H¤£¶}¯Z¡A½Òµ{¬¢¸ß¡C
- ¬°½T«O±zªº¤W½ÒÅv¯q¡A³ø¦W«áY¥¼¦¬¨ì¥ô¦ó¦^ÂСA½Ð¨Ó¹q¬¢¸ß¤è§¹¦¨³ø¦W¡C
- Y³ø¦WªÌ¤£§J°Ñ¥[ªÌ¡A¥i«ü¬£¨ä¥L¤H°Ñ¥[¡A¨Ã©ó¶}½Ò«e¤G¤é³qª¾¡C
- ¦]½Ò«e±Ð§÷¡BÁ¿¸q¤ÎÀ\ÂI¤§·Ç³Æ¡AY±z¤£§J«e¨Ó»Ý¨ú®ø³ø¦W¡A½Ð©ó¶}½Ò«e¤¤é¥HEMAIL³qª¾¥D¿ì³æ¦ìÁpµ¸¤H¨Ã¹q¸Ü½T»{¥Ó½Ð°h¶O¨Æ©y¡A¹O´Á±N¶l±HÁ¿¸q¡A®¤¤£°h¶O¡C
- ¬°´L«Á¿®v¤§´¼¼z°]²£Åv¯q¡A®¤µLªk´£¨Ñ½Òµ{Á¿¸q¹q¤lÀÉ¡C
- ¬°°t¦XÁ¿®v®É¶¡©ÎÁ{®É¬ðµo¨Æ¥ó¡A¥D¿ì³æ¦ì¦³½Õ¾ã¤é´Á©Î§ó´«Á¿®v¤§Åv§Q¡C
- ú¶O¤è¦¡¬°«H¥Î¥d¡BATMÂà±b¡A®¤¤£¨ü²z²{³õ³ø¦W©Mú¶O¡C